TRPV1 and cancer: Our experiments using Annexin V/PI staining and FACS analysis revealed that CBC-induced cell death was significantly affected when CB2 and TRPV1 were silenced using siRNA, indicating that CBC might exert its anti-cancer effects through these two receptors.